Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Ipamorelin versus GHRP-2

GHRP-2 was developed as an improvement over GHRP-6, and it is in some ways. The hunger effect is reduced compared to GHRP-6, though still present. GHRP-2 is more potent for growth hormone release, producing larger GH pulses at equivalent doses. But GHRP-2 stil

This comparison does not assign a generated winner or score.

  • GHRP-2 was developed as an improvement over GHRP-6, and it is in some ways. The hunger effect is reduced compared to GHRP-6, though still present. GHRP-2 is more potent for growth hormone release, producing larger GH pulses at equivalent doses.
  • But GHRP-2 still raises cortisol and prolactin, though to a lesser degree than GHRP-6. It still has effects on blood sugar and has been associated with more concerning adverse events in some clinical contexts. The improved potency comes with a side effect profile that remains significantly more problematic than ipamorelin.
  • Ipamorelin sacrifices some of the raw GH-boosting power for a much cleaner experience. For most applications, this tradeoff is worthwhile. The difference in GH release is not dramatic, but the difference in side effects is substantial.
More references

Related material

Comparison

Ipamorelin versus sermorelin

Sermorelin is a growth hormone releasing hormone analog rather than a ghrelin mimetic like ipamorelin. It works through a different receptor system to achieve similar ends. The si…

View details →
Comparison

Ipamorelin versus GHRP-6

GHRP-6 is an older growth hormone secretagogue with a very different side effect profile. The most notorious difference is hunger. GHRP-6 causes intense, sometimes overwhelming hu…

View details →
Comparison

Ipamorelin versus MK-677

MK-677, also known as ibutamoren, is often compared to ipamorelin though it is not technically a peptide. It is an oral growth hormone secretagogue, which makes it convenient, but…

View details →